Order Center

Use the Order Center to build a Shopping Cart, view Saved Shopping Carts, Recent Orders and Quotes

SDS

Search for SDS (Safety Data Sheet) by Product Number

Oligo Ordering

Custom Products and Services, including DNA oligos (Primers and Probes), RNA, siRNA, Peptide Libraries and AQUA Peptides

Redi-Dri™ for Free-Flowing Hygroscopic Powders

Redi-Dri packaging system eliminates clumping typically noted with many hygroscopic powders and provides a free-flowing, ready-to-use material.

Elérhetoségeink

Customer Service:
Phone: 36 1 235-9055
Email: vevoszolgalat@sial.com

Solvent Center

Visit the Solvent Center to find the right solvent for your specific application. See available products, packaging and special offers.

Email Subscription Center

To receive the information that is relevant to your work, explore our subscription center and set your preferences

Special Offers

Seasonal Offers and specific product promotions for various research topics

Advanced Structure Search

Copy and paste, advanced query features, instant structure to name generation, element analysis and more

News & Information

Darmstadt, Germany - October 19, 2020 Merck KGaA, Darmstadt, Germany Awards Grant to Combined Therapeutics for its Nucleic Acid Platform That, with Virotherapy, Targets Liver Cancer

Merck KGaA, Darmstadt, Germany today announced that Combined Therapeutics Inc., Cambridge, Massachusetts, USA, has been selected as the North American winner of its 2020 Advance Biotech Grant Program.

Read More
Darmstadt, Germany - October 13, 2020 Merck KGaA, Darmstadt, Germany New VirusExpress™ Platform Speeds Development of Cell and Gene Therapies

Merck KGaA, Darmstadt, Germany has bolstered its viral vector manufacturing capabilities with the launch of its VirusExpress™ Lentiviral Production Platform.

Read More
Darmstadt, Germany - October 12, 2020 Merck KGaA, Darmstadt, Germany Licenses CRISPR Genome-Editing Technology to PanCELLa and Takara Bio USA

Merck KGaA, Darmstadt, Germany today announced that it has signed agreements licensing its CRISPR technology to two companies — PanCELLa, a cell therapy firm based in Toronto, Canada and Takara Bio USA, Inc., a biotechnology company based in Mountain View, California, USA.

Read More